However, IL‐33 plays a dual role as IL‐33−/− mice showed an exacerbation of acute DSS colitis due to decreased levels of KC and MIP‐2 and an impaired neutrophil resolution of damage, while exogenous IL‐33 administration attenuated chronic DSS inflammation48, 49. The gene discussed is CALCA; the disease is colitis.